OrbiMed Advisors »

Evommune shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.1M 161k 13.29

More positions owned by OrbiMed Advisors

Edgewise Therapeutics (EWTX)
Enliven Therapeutics (ELVN)
Eli Lilly & Co. (LLY)
Mbx Biosciences (MBX)
Sinovac Biotech SHS
Astrazeneca Ord (AZN)
Structure Therapeutics Sponsored Ads (GPCR)
Sionna Therapeutics (SION)
Corvus Pharmaceuticals (CRVS)
Arrivent Biopharma (AVBP)
Abivax Sa Sponsored Ads Call Option (ABVX)
Guardant Health (GH)
Argenx Se Sponsored Adr (ARGX)
Merck & Co (MRK)
Uniqure Nv SHS (QURE)

View all positions for OrbiMed Advisors

Top funds holding Evommune

EQT Fund Management S.a r.l.
RA Capital Management
Pivotal bioVenture Partners Investment Advisor
Jpmorgan Chase & Co
Rtw Investments
Nan Fung Group Holdings
Point72 Asset Management
Andera Partners
SymBiosis Capital Partners
Eventide Asset Management
T. Rowe Price Associates
Vestal Point Capital
Henderson Group
Jupiter Topco
BlackRock

View all funds holding Evommune